|
Twin randomized studies of daratumumab (DARA; D) plus standard of care (lenalidomide/dexamethasone or bortezomib/dexamethasone [DRd or DVd]) versus Rd or Vd alone in relapsed or refractory multiple myeloma (MM): 54767414MMY3003 (Pollux) and 54767414MMY3004 (Castor). |
| |
|
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Genmab; Janssen-Cilag; Millennium; Onyx; Sanofi |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genmab; Janssen-Cilag; Millennium; Onyx |
| |
|
Honoraria - Celgene; Janssen; Onyx |
Consulting or Advisory Role - Celgene; Janssen; Novartis; Onyx |
Research Funding - Genesis Pharmaceuticals; Janssen |
Travel, Accommodations, Expenses - Celgene; Janssen; Onyx |
| |
|
Honoraria - Amgen; Celgene; Janssen; Lundbeck; Novartis |
Consulting or Advisory Role - Celgene; Janssen; Onyx |
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Novartis; Otsuka |
| |
|
Leadership - Celgene; Janssen; Millennium; Onyx |
Consulting or Advisory Role - Celgene; Janssen; Millennium; Onyx |
Research Funding - Celgene; Janssen; Millennium; Onyx |
| |
|
|
Consulting or Advisory Role - Janssen |
Speakers' Bureau - Janssen |
Research Funding - Janssen |
Travel, Accommodations, Expenses - Janssen |
| |
Asher Alban Akmal Chanan-Khan |
No Relationships to Disclose |
| |
|
Employment - GlaxoSmithKline (I) |
Honoraria - Celgene; Chugai Pharma; Janssen; Millennium; Novartis; Onyx |
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen (Inst); Millennium (Inst); Novartis (Inst); Onyx (Inst) |
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Chugai Pharma (Inst); Janssen (Inst); Novartis (Inst) |
| |
|
Employment - Janssen Research & Development |
| |
|
Employment - Janssen Research & Development |
| |
|
No Relationships to Disclose |
| |
|
Employment - Janssen Research & Development |
| |
|
Employment - Janssen Research & Development |
| |
|
Employment - Janssen Research & Development |
| |
|
Consulting or Advisory Role - Acetylon Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Celgene; Janssen; Millennium; Onyx |
Research Funding - Array BioPharma; Bristol-Myers Squibb; Celgene; Millennium; Onyx; Spectrum Pharmaceuticals |